Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Equity (Deficiency)

v3.21.1
Condensed Consolidated Statements of Equity (Deficiency) - USD ($)
shares in Thousands, $ in Thousands
Preferred Stock [Member]
Common Stock
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Noncontrolling Interest [Member]
Total
Balance at Jun. 30, 2019   $ 20 $ 108,295 $ (31) $ (105,821) $ (6) $ 2,457
Balance (in shares) at Jun. 30, 2019 10 20,152          
Conversion of preferred stock to common stock   $ 4 (4)        
Conversion of preferred stock to common stock (in shares) (4) 4,000          
Share-based compensation     68       68
Foreign currency translation adjustment       (1)     (1)
Net loss         (4,463) (1) (4,464)
Balance at Sep. 30, 2019   $ 24 108,359 (32) (110,284) (7) (1,940)
Balance (in shares) at Sep. 30, 2019 6 24,152          
Balance at Jun. 30, 2019   $ 20 108,295 (31) (105,821) (6) 2,457
Balance (in shares) at Jun. 30, 2019 10 20,152          
Issuance of notes payable under warrant exchange             3,300
Compensation shares             1
Deemed dividends – down round of Series A Preferred and Series B Preferred             21,560
Foreign currency translation adjustment             (2)
Net loss             (12,904)
Balance at Mar. 31, 2020   $ 107 150,774 (33) (146,882) (9) 3,957
Balance (in shares) at Mar. 31, 2020 6 107,360          
Balance at Sep. 30, 2019   $ 24 108,359 (32) (110,284) (7) (1,940)
Balance (in shares) at Sep. 30, 2019 6 24,152          
Capital raises   $ 2 4,513       4,515
Capital raise (in shares) 5 2,450          
Costs to raise capital     (60)       (60)
Compensation shares   $ 1 (1)        
Compensation shares (in shares)   500          
Exercise of warrants   $ 3 688       691
Exercise of warrants (in shares)   3,140          
Deemed dividends – down round of Series A Preferred and Series B Preferred     21,560   (21,560)    
Conversion of preferred stock to common stock   $ 25 (25)        
Conversion of preferred stock to common stock (in shares) (5) 24,325          
Share-based compensation     37       37
Foreign currency translation adjustment       1     1
Net loss         (3,762) (2) (3,764)
Balance at Dec. 31, 2019   $ 55 135,071 (31) (135,606) (9) (520)
Balance (in shares) at Dec. 31, 2019 6 54,567          
Warrant exchange   $ 15 3,285   (3,300)    
Warrant exchange (in shares)   15,000          
Issuance of notes payable under warrant exchange         (3,300)   (3,300)
Capital raises   $ 5 5,761       5,766
Capital raise (in shares)   5,000          
Costs to raise capital     (321)       (321)
Compensation shares (in shares)   816          
Exercise of warrants   $ 32 6,912       6,944
Exercise of warrants (in shares)   31,860          
Exercise of stock options     3       3
Exercise of stock options (in shares)   4          
Conversion of preferred stock to common stock (in shares)   113          
Share-based compensation     63       63
Foreign currency translation adjustment       (2)     (2)
Net loss         (4,676)   (4,676)
Balance at Mar. 31, 2020   $ 107 150,774 (33) (146,882) (9) 3,957
Balance (in shares) at Mar. 31, 2020 6 107,360          
Balance at Jun. 30, 2020   $ 140 206,931 (33) (150,420) (11) 56,607
Balance (in shares) at Jun. 30, 2020 6 140,071          
Capital raises   $ 11 32,111       32,122
Capital raise (in shares)   11,292          
Costs to raise capital     (1,525)       (1,525)
Exercise of stock options     28       28
Exercise of stock options (in shares)   30          
Conversion of preferred stock to common stock   $ 29 (29)        
Conversion of preferred stock to common stock (in shares) (6) 28,925          
Share-based compensation     351       351
Unrealized loss on debt securities       (7)     (7)
Net loss         (7,533) (1) (7,534)
Balance at Sep. 30, 2020   $ 180 237,867 (40) (157,953) (12) 80,042
Balance (in shares) at Sep. 30, 2020   180,318          
Balance at Jun. 30, 2020   $ 140 206,931 (33) (150,420) (11) 56,607
Balance (in shares) at Jun. 30, 2020 6 140,071          
Unrealized loss on debt securities             (36)
Foreign currency translation adjustment             0
Net loss             (23,327)
Balance at Mar. 31, 2021   $ 216 278,442 (70) (173,743) (15) 104,830
Balance (in shares) at Mar. 31, 2021   216,133          
Balance at Sep. 30, 2020   $ 180 237,867 (40) (157,953) (12) 80,042
Balance (in shares) at Sep. 30, 2020   180,318          
Capital raises   $ 32 38,243       38,275
Capital raise (in shares)   31,451          
Costs to raise capital     (3,117)       (3,117)
Share-based compensation     265       265
Unrealized loss on debt securities       (13)     (13)
Net loss         (8,129) (2) (8,131)
Balance at Dec. 31, 2020   $ 212 273,258 (53) (166,082) (14) 107,321
Balance (in shares) at Dec. 31, 2020   211,769          
Capital raises $ 0 $ 4 4,880 0 0 0 4,884
Capital raise (in shares) 0 4,354          
Costs to raise capital     $ (71)       $ (71)
Costs to raise capital (in shares)   10          
Exercise of stock options (in shares)     1       1
Share-based compensation     $ 374       $ 374
Unrealized loss on debt securities       (16)     (16)
Foreign currency translation adjustment       (1)     (1)
Net loss         (7,661) (1) (7,662)
Balance at Mar. 31, 2021   $ 216 $ 278,442 $ (70) $ (173,743) $ (15) $ 104,830
Balance (in shares) at Mar. 31, 2021   216,133